Cargando…

The role of subregions of the rat major histocompatibility complex in the rejection and passive enhancement of renal allografts

The laboratory recombinant haplotype H-1acl of the Norway rat has been used in studies of the rejection and passive enhancement of kidney allografts. While the full H-1a haplotype provoked acute rejection, neither of the isolated subregions, H-1Aa and H-1Ba, did so. It was also found that alloantise...

Descripción completa

Detalles Bibliográficos
Formato: Texto
Lenguaje:English
Publicado: The Rockefeller University Press 1979
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2184738/
https://www.ncbi.nlm.nih.gov/pubmed/368285
_version_ 1782145690952007680
collection PubMed
description The laboratory recombinant haplotype H-1acl of the Norway rat has been used in studies of the rejection and passive enhancement of kidney allografts. While the full H-1a haplotype provoked acute rejection, neither of the isolated subregions, H-1Aa and H-1Ba, did so. It was also found that alloantisera raised against either the H-1Aa or the H- 1Ba antigens would enhance the grafts. It is suggested that both MHC subregions contain a histocompatibility locus (i) for kidney (as they do for skin) and that in the genetic combinations studied only incompatibility for both provokes a response sufficient for rejection. In other combinations, however, single region incompatibilities may be sufficient.
format Text
id pubmed-2184738
institution National Center for Biotechnology Information
language English
publishDate 1979
publisher The Rockefeller University Press
record_format MEDLINE/PubMed
spelling pubmed-21847382008-04-17 The role of subregions of the rat major histocompatibility complex in the rejection and passive enhancement of renal allografts J Exp Med Articles The laboratory recombinant haplotype H-1acl of the Norway rat has been used in studies of the rejection and passive enhancement of kidney allografts. While the full H-1a haplotype provoked acute rejection, neither of the isolated subregions, H-1Aa and H-1Ba, did so. It was also found that alloantisera raised against either the H-1Aa or the H- 1Ba antigens would enhance the grafts. It is suggested that both MHC subregions contain a histocompatibility locus (i) for kidney (as they do for skin) and that in the genetic combinations studied only incompatibility for both provokes a response sufficient for rejection. In other combinations, however, single region incompatibilities may be sufficient. The Rockefeller University Press 1979-01-01 /pmc/articles/PMC2184738/ /pubmed/368285 Text en This article is distributed under the terms of an Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publication date (see http://www.rupress.org/terms). After six months it is available under a Creative Commons License (Attribution–Noncommercial–Share Alike 4.0 Unported license, as described at http://creativecommons.org/licenses/by-nc-sa/4.0/).
spellingShingle Articles
The role of subregions of the rat major histocompatibility complex in the rejection and passive enhancement of renal allografts
title The role of subregions of the rat major histocompatibility complex in the rejection and passive enhancement of renal allografts
title_full The role of subregions of the rat major histocompatibility complex in the rejection and passive enhancement of renal allografts
title_fullStr The role of subregions of the rat major histocompatibility complex in the rejection and passive enhancement of renal allografts
title_full_unstemmed The role of subregions of the rat major histocompatibility complex in the rejection and passive enhancement of renal allografts
title_short The role of subregions of the rat major histocompatibility complex in the rejection and passive enhancement of renal allografts
title_sort role of subregions of the rat major histocompatibility complex in the rejection and passive enhancement of renal allografts
topic Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2184738/
https://www.ncbi.nlm.nih.gov/pubmed/368285